Ownership Filing for InMed Pharmaceuticals Inc. by Vivo Opportunity

This filing details the ownership of InMed Pharmaceuticals Inc. (INM) by Vivo Opportunity, LLC and its associated funds. The reporting owners, including Vivo Opportunity, LLC, Vivo Opportunity Fund Holdings, L.P., Vivo Opportunity Cayman Fund, L.P., and Vivo Opportunity Cayman, LLC, are all identified as ten percent owners. The filing indicates indirect ownership of common shares. Following the reporting period, Vivo Opportunity Fund Holdings, L.P. holds 492,073 common shares, and Vivo Opportunity Cayman Fund, L.P. holds 49,679 common shares. The footnotes clarify the general partner relationship and disclaimers of beneficial ownership for Vivo Opportunity, LLC and Vivo Opportunity Cayman, LLC, except to the extent of their pecuniary interest.